When Managing Low-Risk Patients With Chest Pain In The Emergency Department, Cardiac CT Is More Cost Effective
The use of cardiac CT for low-risk chest pain patients in the emergency department, instead of the traditional standard of care (SOC) workup, may reduce a patient's length of stay and hospital charges, according to a study performed at the University of Washington School of Medicine, Seattle, WA. The SOC workup, which is timely and expensive, consists of a series of cardiac enzyme tests, ECGs and nuclear stress testing. Fifty patients were included in the study. "We found that cardiac CT based workups in low risk chest pain patients decreased the length of hospital stay up to 20 hours and was significantly cheaper (44% less) than using the standard of care workup, " said Janet May, MS, lead author of the study.
A surgeon at the St. Francis Heart Center is using a revolutionary technology that allows patients to rebuild their own cardiovascular tissue. Marc Gerdisch, M.D., is using the CorMatrix Extracellular Matrix (ECM)(TM) to modify and repair cardiac structures, allowing heart tissue to re-grow inside the beating hearts of heart surgery patients. The CorMatrix ECM is a unique biomaterial that harnesses the body's innate ability to repair damaged heart tissue. Over time, it is replaced by the patients' own tissue. "The use of this biomaterial is a major advancement in cardiac surgery and allows us to provide our patients with restoration of normal anatomic structures.
Improving Care For Cardiac Patients Is Centerpiece Of American Society Of Nuclear Cardiology Meeting
The American Society of Nuclear Cardiology will host its 14th Annual Scientific Session October 1 - 4, 2009 in Minneapolis, MN. Imaging specialists from around the world will gather at ASNC2009 to discuss the meeting's theme - "Quality and Patient-Centered Outcomes in Cardiac Imaging." With original scientific abstract poster sessions, dynamic lectures, and late-breaking clinical trial presentations, the ASNC Annual Scientific Session is critical to advancing best practices and new research in the field of cardiovascular imaging. More than 1, 000 physicians, scientists, technologists, and nurses will attend this year's meeting, which will feature lectures from esteemed faculty such as Dr.
Preventive operations are being used more and more often to treat abdominal aortic aneurysms. Even though the operation is now being offered to ever older and sicker patients, the long-term survival of those who have had the operation has improved over the last two decades. This is shown in a major Swedish study in which researchers from Uppsala University examined 12, 000 patients. The findings are published in Circulation: Journal of the American Heart Association. Each year between 700 and 1, 000 Swedes die as a result of rupture of abdominal aortic aneurysms. The number of preventive operations is on the rise throughout the Western world, for one thing because the population is growing older and also because with new methods it is possible today to treat older and sicker patients.
QRESEARCH Team Welcome New Validation Of QRISK formula for identifying those most at risk of developing heart disease
The University of Nottingham and leading healthcare systems supplier EMIS welcomed a new, independent validation of the QRISK formula for identifying those most at risk of developing heart disease. The two organisations worked together, through the not-for-profit partnership QResearch, to develop the ground-breaking formula which has been strongly endorsed in new research published in the BMJ. Researchers from the University of Oxford have recommended its widespread use across the UK in place of the more commonly-used Framingham equation. Commenting on the new research, Professor Julia Hippisley-Cox of The University of Nottingham's Division of Primary Care, said: "We are delighted to receive another strong endorsement of the value of QRISK in assessing the risk of heart disease in the UK population.
Yale University researchers have found that a single gene plays a key role in the development of atherosclerosis in mice. The research provides insight into the causes of atherosclerosis, or the hardening of the arteries caused by a buildup of plaque. The research appears in the July 8th issue of the journal Cell Metabolism. Accumulation of low-density lipoprotein (LDL) cholesterol in the artery wall is the initial event in atherosclerosis, but the mechanism of how the LDL infiltrates vascular lining to reach the arterial wall has been unclear. The Yale team discovered that, when active, the caveolin-1 (Cav-1) gene, which is essential for orchestrating certain intracellular trafficking, promoted atherosclerotic lesions.